HER2 inhibition: From discovery to clinical practice

被引:41
作者
Chang, Jenny C. [1 ]
机构
[1] Baylor Coll Med, Breast Ctr, Houston, TX 77030 USA
关键词
D O I
10.1158/1078-0432.CCR-06-2405
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1 / 3
页数:3
相关论文
共 35 条
[31]  
STORNIOLO A, 2005, P AN M AM SOC CLIN, V23, P559
[32]  
TSUDA H, 1989, CANCER RES, V49, P3104
[33]  
VARLEY JM, 1987, ONCOGENE, V1, P423
[34]   AN EVALUATION OF IMMUNOREACTIVITY FOR C-ERBB-2-PROTEIN AS A MARKER OF POOR SHORT-TERM PROGNOSIS IN BREAST-CANCER [J].
WALKER, RA ;
GULLICK, WJ ;
VARLEY, JM .
BRITISH JOURNAL OF CANCER, 1989, 60 (03) :426-429
[35]  
WRIGHT C, 1989, CANCER RES, V49, P2087